13F filer · CIK 1574661
March Altus Capital Management LP
Greenwich, CT · filing since Q4 2013 · last filing Nov 7, 2016
Reported value
$16.0M
+$3.0M vs prior
Positions
11
New / sold out
4 / 1
Added / reduced
2 / 3
Turnover
21.4%
buys $5.0M · sells $3.1M
Top-10 weight
98.7%
Biggest buys vs Q2 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | EDWARDS LIFESCIENCES CORP | +16,000 | +86.0% | +$1.9M |
| New | TESARO INC | +10,000 | – | +$1.0M |
| New | ZOETIS INC | +15,900 | – | +$827.0K |
| New | BIOGEN INC | +2,600 | – | +$814.0K |
| Added | DEXCOM INC | +2,500 | +21.4% | +$219.2K |
| New | REGENERON PHARMACEUTICALS | +500 | – | +$201.0K |
Biggest sells vs Q2 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ALIGN TECHNOLOGY INC | -17,319 | -100.0% | $-1.4M |
| Reduced | LLYLILLY ELI & CO | -13,500 | -50.4% | $-1.1M |
| Reduced | ACADIA PHARMACEUTICALS INC | -10,000 | -12.1% | $-318.1K |
| Reduced | ALEXION PHARMACEUTICALS INC | -2,400 | -27.9% | $-294.2K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2016
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | EDWARDS LIFESCIENCES CORPCOM | 34,611 | $4.2M | 26.11% |
| 2 | ACADIA PHARMACEUTICALS INCCOM | 72,723 | $2.3M | 14.47% |
| 3 | ARATANA THERAPEUTICS INCCOM | 218,515 | $2.0M | 12.79% |
| 4 | JNJJOHNSON & JOHNSON | 13,000 | $1.5M | 9.61% |
| 5 | DEXCOM INCCOM | 14,200 | $1.2M | 7.79% |
| 6 | LLYLILLY ELI & CO | 13,310 | $1.1M | 6.68% |
| 7 | TESARO INCCOM | 10,000 | $1.0M | 6.27% |
| 8 | ZOETIS INCCL A | 15,900 | $827.0K | 5.17% |
| 9 | BIOGEN INCCOM | 2,600 | $814.0K | 5.09% |
| 10 | ALEXION PHARMACEUTICALS INCCOM | 6,199 | $760.0K | 4.75% |
1 more rows. Subscribe for $29/month to see every row, download the data and use the API.